Hydrogen Research Study
← Back to Research Library
Preclinical animal evidenceAnimal studyOther or not reported

Hydrogen protects lung from hypoxia/re-oxygenation injury by reducing hydroxyl radical production and inhibiting inflammatory responses.

Meihong Chen, Jie Zhang, Yun Chen, Yan Qiu, Zi Luo, Sixia Zhao, Lei Du, Dongbo Tian · Scientific reports · 2018

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Inflammation and Immune Regulation
Evidence type Preclinical animal evidence
Publication type Animal study
Hydrogen method Other or not reported

H2HUBB TAKEAWAY

In mice, however, H₂ did not substantially affect the H/R-induced increase in erythropoietin or pulmonary artery remodeling. These results are preclinical and suggest that molecular hydrogen did not improve the measured outcome. Further human research is needed to determine its clinical relevance.

What the Researchers Studied

The study examined mice.

How Molecular Hydrogen Was Used

Molecular hydrogen was administered as here the researchers investigated whether hydrogen can protect the lung from chronic injury induced by hypoxia/re-oxygenation (h/r). h₂ attenuated h/r-induced production of hydroxyl radicals, up-regulation of colony-stimulating factors, and recruitment of neutrophils and m1 macrophages to lung tissues. however, h₂ did not substantially affect the h/r-induced increase in erythropoietin or pulmonary artery remodeling.

What the Researchers Found

However, H₂ did not substantially affect the H/R-induced increase in erythropoietin or pulmonary artery remodeling.

H₂ Mechanisms / Biological Findings

The source material reviewed did not establish a specific molecular hydrogen mechanism for the reported findings.

Authors’ Conclusion

The authors concluded that H₂ ameliorates H/R-induced lung injury by inhibiting hydroxyl radical production and inflammation in lungs.